Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Immunity and Cancer, Francis Crick Institute, London, United Kingdom.
PLoS Pathog. 2021 Nov 8;17(11):e1010069. doi: 10.1371/journal.ppat.1010069. eCollection 2021 Nov.
ES-62 is the major secreted protein of the parasitic filarial nematode, Acanthocheilonema viteae. The molecule exists as a large tetramer (MW, ~240kD), which possesses immunomodulatory properties by virtue of multiple phosphorylcholine (PC) moieties attached to N-type glycans. By suppressing inflammatory immune responses, ES-62 can prevent disease development in certain mouse models of allergic and autoimmune conditions, including joint pathology in collagen-induced arthritis (CIA), a model of rheumatoid arthritis (RA). Such protection is associated with functional suppression of "pathogenic" hyper-responsive synovial fibroblasts (SFs), which exhibit an aggressive inflammatory and bone-damaging phenotype induced by their epigenetic rewiring in response to the inflammatory microenvironment of the arthritic joint. Critically, exposure to ES-62 in vivo induces a stably-imprinted CIA-SF phenotype that exhibits functional responses more typical of healthy, Naïve-SFs. Consistent with this, ES-62 "rewiring" of SFs away from the hyper-responsive phenotype is associated with suppression of ERK activation, STAT3 activation and miR-155 upregulation, signals widely associated with SF pathogenesis. Surprisingly however, DNA methylome analysis of Naïve-, CIA- and ES-62-CIA-SF cohorts reveals that rather than simply preventing pathogenic rewiring of SFs, ES-62 induces further changes in DNA methylation under the inflammatory conditions pertaining in the inflamed joint, including targeting genes associated with ciliogenesis, to programme a novel "resolving" CIA-SF phenotype. In addition to introducing a previously unsuspected aspect of ES-62's mechanism of action, such unique behaviour signposts the potential for developing DNA methylation signatures predictive of pathogenesis and its resolution and hence, candidate mechanisms by which novel therapeutic interventions could prevent SFs from perpetuating joint inflammation and destruction in RA. Pertinent to these translational aspects of ES-62-behavior, small molecule analogues (SMAs) based on ES-62's active PC-moieties mimic the rewiring of SFs as well as the protection against joint disease in CIA afforded by the parasitic worm product.
ES-62 是寄生性丝虫 Acanthocheilonema viteae 的主要分泌蛋白。该分子以四聚体的形式存在(MW,~240kD),由于附着在 N 型糖链上的多个磷酸胆碱(PC)部分,具有免疫调节特性。通过抑制炎症免疫反应,ES-62 可以预防某些过敏和自身免疫疾病的小鼠模型中的疾病发展,包括胶原诱导关节炎(CIA)中的关节病理学,这是类风湿关节炎(RA)的模型。这种保护与“致病”高反应性滑膜成纤维细胞(SFs)的功能抑制有关,这些细胞在炎症性关节炎关节的炎症微环境中表现出由表观遗传重排诱导的侵袭性炎症和骨破坏表型。至关重要的是,体内暴露于 ES-62 会诱导 CIA-SF 表型的稳定印迹,该表型表现出更典型的健康、幼稚 SF 的功能反应。与此一致,SF 从高反应性表型的 ES-62“重排”与 ERK 激活、STAT3 激活和 miR-155 上调的抑制有关,这些信号广泛与 SF 发病机制有关。然而,令人惊讶的是,幼稚、CIA 和 ES-62-CIA-SF 队列的 DNA 甲基组分析表明,ES-62 并没有简单地阻止 SF 的致病重排,而是在炎症关节中存在的炎症条件下,进一步改变 DNA 甲基化,包括靶向与纤毛发生相关的基因,以编程一种新型“解决”的 CIA-SF 表型。除了引入 ES-62 作用机制的一个以前未被怀疑的方面外,这种独特的行为标志着开发预测发病机制及其解决的 DNA 甲基化特征的潜力,因此也标志着新型治疗干预措施可以防止 SF 持续引发 RA 关节炎症和破坏的候选机制。与 ES-62 行为的这些转化方面相关的是,基于 ES-62 活性 PC 部分的小分子类似物(SMAs)模拟 SF 的重排以及寄生虫产物对 CIA 中关节疾病的保护。